Cadrenal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	17	26	10	-
Market Cap Growth	-40.67%	168.05%	-	-
Enterprise Value	14	21	1	-
Last Close Price	7.64	14.49	11.10	-
PB Ratio	5.75	3.47	1.25	-
P/TBV Ratio	6.53	3.47	1.25	-
Debt / Equity Ratio	-	-	0.00	-0.11
Quick Ratio	2.86	3.75	10.21	0.02
Current Ratio	3.02	3.77	10.27	0.55
Return on Equity (ROE)	-468.03%	-140.78%	-780.59%	-
Return on Assets (ROA)	-209.23%	-73.49%	-102.62%	-
Return on Capital Employed (ROCE)	-536.60%	-147.30%	-99.20%	529.80%
Earnings Yield	-80.53%	-41.24%	-86.73%	-
FCF Yield	-66.25%	-28.51%	-36.67%	-
Buyback Yield / Dilution	-47.19%	-35.59%	-70.99%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q